TERN-101

DRUG2 trials

Sponsors

Terns, Inc.

Conditions

NASH - Nonalcoholic Steatohepatitis

Phase 2

LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)

CompletedNCT04328077

Terns, Inc.NASH - Nonalcoholic Steatohepatitis

Start: 2020-06-18End: 2021-05-19Updated: 2022-08-09

DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis

CompletedNCT05415722

Terns, Inc.NASH - Nonalcoholic Steatohepatitis

Start: 2022-06-28End: 2023-07-10Updated: 2025-03-12

Related Papers

TERN-501 monotherapy and combination therapy with TERN-101 in metabolic dysfunction-associated steatohepatitis: the randomized phase 2a DUET trial.

2025-06-112 citations

NAFLD and NAFLD Related HCC: Emerging Treatments and Clinical Trials.

2025-01-019 citations